Medtronic Stock Analysis (NYSE:MDT)

Add to My Stocks
$75.82 $0.73 (0.97%) MDT stock closing price Jan 17, 2017 (Closing)
Watch Robo Advisor Video of MDT Stock Analysis
Medtronic
Updated on : Jan 17, 2017
previous close
MDT 75.8 (0%)
S&P 500 2267.9 (0%)
Closing Price On: Jan 17, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q2
$billion
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
12%
Operating Profit
Operating Margin:
18.2%
Sector Average:
-1.3%
5 Quarter Net Profit
Net Margins
2017-Q2
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
32.38B
Debt/Equity Ratio:
 0.64
Compared to the industry
Cash Flow
Operating cash flow:
$1.47B
Net Income:
$1.12B
Dividend Yield
MDT dividend yield:
2.14%
PROS      CONS
Operating Margins
Net Margins
ROIC
ROE
FCF Margin
PE Valuation
Recent Growth
Long Term Growth
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
MDT PS :
3.6
Industry PS :
4.5
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
6.5%
Return on Equity:
8.3%
Free Cash Flow Margin:
16.4%
Double Tap To Exit Full Screen
0:00
/

Medtronic Analysis Video

566 5 2 1

View Medtronic stock analysis video. This is our MDT analyst opinion covering the buy and sell arguments for MDT stock.

Medtronic PLC Stock Rating (3.6/5)

Our Medtronic stock opinion is based on fundamentals of the company. This Medtronic stock analysis is based on latest Q2 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy MDT stock?

  • Medtronic had a healthy average operating margin of 18.2% over the last 4 quarters.
  • LTM Net margins were good at 14.6% for Medtronic.
  • MDT stock is trading at an earnings multiple of 16.9 which is better than the industry average of 21.9.
  • Medtronic generates a high return on invested capital of 6.5%.
  • Medtronic has a good Return On Equity (ROE) of 8.3%.
  • The company has a good Free Cash Flow (FCF) margin of 16.4%.

Should you sell MDT stock?

  • Medtronic had a low YoY revenue growth of 4.1% in the 2017 Q2.
  • Revenue growth of has been weak over the last 5 years.
  • Medtronic has a debt/equity ratio of  0.64, which is worse than the average in the Medical sector.

Comments on this video and Medtronic stock

arnulacroix22 on Medtronic stock analysis ($78.79)
bullish
Watch Medtronic plc (MDT) stock, which reached a new all-time high in intraday trading on Friday's market activity. Check this out http://finance.crwe-pr.com/2015/02/20/me...
reply